Global Oxytocic Pharmaceuticals Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147452
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 130
  • list Pharmaceuticals and Healthcare

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.

Scope of the Report:

This report focuses on the Oxytocic Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.

The worldwide market for Oxytocic Pharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Fresenius Kaci

Biofutura

Baxter

Pfizer

Ferring

Novartis

Teva

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Natural Oxytocin

Synthetic Oxytocin Derivative

Market Segment by Applications, can be divided into

Abortion Induced Incomplete

Inevitable Abortion

Post-partum Haemorrhage

Labour Induction

Labour Arrest

There are 15 Chapters to deeply display the global Oxytocic Pharmaceuticals market.

Chapter 1, to describe Oxytocic Pharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oxytocic Pharmaceuticals, with sales, revenue, and price of Oxytocic Pharmaceuticals, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oxytocic Pharmaceuticals, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oxytocic Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oxytocic Pharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Oxytocic Pharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Natural Oxytocin

1.2.2 Synthetic Oxytocin Derivative

1.3 Market Analysis by Applications

1.3.1 Abortion Induced Incomplete

1.3.2 Inevitable Abortion

1.3.3 Post-partum Haemorrhage

1.3.4 Labour Induction

1.3.5 Labour Arrest

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Fresenius Kaci

2.1.1 Business Overview

2.1.2 Oxytocic Pharmaceuticals Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Fresenius Kaci Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Biofutura

2.2.1 Business Overview

2.2.2 Oxytocic Pharmaceuticals Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biofutura Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Baxter

2.3.1 Business Overview

2.3.2 Oxytocic Pharmaceuticals Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Baxter Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Oxytocic Pharmaceuticals Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Pfizer Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Ferring

2.5.1 Business Overview

2.5.2 Oxytocic Pharmaceuticals Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Ferring Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Novartis

2.6.1 Business Overview

2.6.2 Oxytocic Pharmaceuticals Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Novartis Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Teva

2.7.1 Business Overview

2.7.2 Oxytocic Pharmaceuticals Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Teva Oxytocic Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oxytocic Pharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oxytocic Pharmaceuticals Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oxytocic Pharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oxytocic Pharmaceuticals Manufacturer Market Share in 2017

3.3.2 Top 6 Oxytocic Pharmaceuticals Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oxytocic Pharmaceuticals Market Analysis by Regions

4.1 Global Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Regions

4.1.1 Global Oxytocic Pharmaceuticals Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oxytocic Pharmaceuticals Revenue and Market Share by Regions (2013-2018)

4.2 North America Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

4.3 Europe Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

4.5 South America Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

5 North America Oxytocic Pharmaceuticals by Countries

5.1 North America Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Countries

5.1.1 North America Oxytocic Pharmaceuticals Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oxytocic Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

5.2 United States Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

5.3 Canada Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

5.4 Mexico Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

6 Europe Oxytocic Pharmaceuticals by Countries

6.1 Europe Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Countries

6.1.1 Europe Oxytocic Pharmaceuticals Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oxytocic Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

6.3 UK Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

6.4 France Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

6.5 Russia Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

6.6 Italy Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oxytocic Pharmaceuticals by Countries

7.1 Asia-Pacific Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oxytocic Pharmaceuticals Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oxytocic Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

7.2 China Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

7.3 Japan Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

7.4 Korea Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

7.5 India Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

8 South America Oxytocic Pharmaceuticals by Countries

8.1 South America Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Countries

8.1.1 South America Oxytocic Pharmaceuticals Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oxytocic Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

8.3 Argentina Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

8.4 Colombia Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oxytocic Pharmaceuticals by Countries

9.1 Middle East and Africa Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oxytocic Pharmaceuticals Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oxytocic Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

9.3 UAE Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

9.4 Egypt Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

9.5 Nigeria Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

9.6 South Africa Oxytocic Pharmaceuticals Sales and Growth Rate (2013-2018)

10 Global Oxytocic Pharmaceuticals Market Segment by Type

10.1 Global Oxytocic Pharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oxytocic Pharmaceuticals Sales and Market Share by Type (2013-2018)

10.1.2 Global Oxytocic Pharmaceuticals Revenue and Market Share by Type (2013-2018)

10.2 Natural Oxytocin Sales Growth and Price

10.2.1 Global Natural Oxytocin Sales Growth (2013-2018)

10.2.2 Global Natural Oxytocin Price (2013-2018)

10.3 Synthetic Oxytocin Derivative Sales Growth and Price

10.3.1 Global Synthetic Oxytocin Derivative Sales Growth (2013-2018)

10.3.2 Global Synthetic Oxytocin Derivative Price (2013-2018)

11 Global Oxytocic Pharmaceuticals Market Segment by Application

11.1 Global Oxytocic Pharmaceuticals Sales Market Share by Application (2013-2018)

11.2 Abortion Induced Incomplete Sales Growth (2013-2018)

11.3 Inevitable Abortion Sales Growth (2013-2018)

11.4 Post-partum Haemorrhage Sales Growth (2013-2018)

11.5 Labour Induction Sales Growth (2013-2018)

11.6 Labour Arrest Sales Growth (2013-2018)

12 Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.1 Global Oxytocic Pharmaceuticals Sales, Revenue and Growth Rate (2018-2023)

12.2 Oxytocic Pharmaceuticals Market Forecast by Regions (2018-2023)

12.2.1 North America Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.2.2 Europe Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.2.4 South America Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oxytocic Pharmaceuticals Market Forecast (2018-2023)

12.3 Oxytocic Pharmaceuticals Market Forecast by Type (2018-2023)

12.3.1 Global Oxytocic Pharmaceuticals Sales Forecast by Type (2018-2023)

12.3.2 Global Oxytocic Pharmaceuticals Market Share Forecast by Type (2018-2023)

12.4 Oxytocic Pharmaceuticals Market Forecast by Application (2018-2023)

12.4.1 Global Oxytocic Pharmaceuticals Sales Forecast by Application (2018-2023)

12.4.2 Global Oxytocic Pharmaceuticals Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Oxytocic Pharmaceuticals Picture

Table Product Specifications of Oxytocic Pharmaceuticals

Figure Global Sales Market Share of Oxytocic Pharmaceuticals by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery